Kathryn E Wengel insider trades

Open-market stock purchases and sales by Kathryn E Wengel, EVP, Chief TO and Risk Officer at Johnson & Johnson, from SEC Form 4 filings since Dec 12, 2019.

Recent trades

DateStockTradeValue
Jun 11, 2026JNJ Johnson & JohnsonSold$2.4M
Jun 11, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 15, 2026JNJ Johnson & JohnsonSold (not open market)$75.5K
Feb 15, 2026JNJ Johnson & JohnsonSold (not open market)$79.1K
Feb 13, 2026JNJ Johnson & JohnsonSold (not open market)$53.1K
Feb 13, 2026JNJ Johnson & JohnsonSold (not open market)$1.6M
Feb 13, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 13, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 11, 2026LH Labcorp Holdings IncBought (not open market)—
Feb 10, 2026LH Labcorp Holdings IncBought (not open market)—
Feb 9, 2026JNJ Johnson & JohnsonBought (not open market)—
Feb 6, 2026JNJ Johnson & JohnsonSold (not open market)$6.5M
Feb 6, 2026JNJ Johnson & JohnsonBought (not open market)$4M

Companies traded

  • JNJ Johnson & Johnson: 10 sales, last Jun 11, 2026
  • LH Labcorp Holdings Inc: other filings, last Feb 11, 2026

Get free alerts when Kathryn E Wengel files a new trade →